The changes in the level of CP confirmed the results of Shenoy et al. [239], who reported that the elevation of ceruloplasmin in psoriasis patients occurred in the acute phase of inflammatory response and could reflect its scavenging action on highly toxic hydroxyl radicals produced during the inflammatory process. Here, CP is linked to psoriasis.